| Filed On | Filing |
|---|---|
| 05 Feb 2024 |
8-K/A: Financial Statements and Exhibits
On November 17, 2023 (the “Closing Date”), Zevra Therapeutics, Inc., a Delaware corporation (“Zevra” or the “Company”) completed the previously announced acquisition of Acer Therapeutics Inc., a Delaware corporation (“Acer”), pursuant to... |
| 24 Nov 2020 | 8-K/A: Other Events |
| 30 Oct 2020 | 8-K/A: Results of Operations and Financial Condition |
| 19 Jun 2020 | 8-K/A: Regulation FD Disclosure |
| 23 May 2017 | 8-K/A: Results of Operations and Financial Condition |
Loading...
